Primary coronary stenting for treatment of acute myocardial infarction

Nurhay Abdurahman, Teguh Santoso Sukamto, Hanafi BinartoTrisnohadi, Mikail N.T. Wangge, Dasnan Ismail

Research output: Contribution to journalArticlepeer-review


The use of intravenous thrombolytic therapy has emerged as one of the most important pharmacological intervention in acute myocardial infarction, since by restoring blood flow in the occluded infarct related artery, it may preserve viable myocardial tissue, protect left ventricular function and reduce mortality. However, such approach only aims to dissolve the acute coronary thrombus and leave the underlying atherosclerotic plaque untreated. Another alternative is mechanical intervention by means of primary coronary angioplasty (primary PTCA). However, vessel reocclusion and late restenosis after successful PTCA remain a problem. We reported our initial experience with primary coronary stenting in 6 patients. Success rate was 100% with no death, reinfarction and recurrent ischemia. At short-medium follow-up there were no adverse major cardiac events and target vessel revascularization was not required. Further studies are required to prove the safety and feasibility of this treatment strategy.

Original languageEnglish
Pages (from-to)84-88
Number of pages5
JournalMedical Journal of Indonesia
Issue number2
Publication statusPublished - 1 Apr 1998


  • Acute myocardial infarction
  • Angioplasty
  • Stenting


Dive into the research topics of 'Primary coronary stenting for treatment of acute myocardial infarction'. Together they form a unique fingerprint.

Cite this